Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
By Noriho Iida, A. Dzutsev, C. Stewart, Loretta Smith, N. Bouladoux, Rebecca A. Weingarten, D. Molina, R. Salcedo, T. Back, Sarah D. Cramer and 11 more. Science, 2013
2,030 citations recorded by the source corpus.
The Microbiota Makes for Good Therapy The gut microbiota has been implicated in the development of some cancers, such as colorectal cancer, but—given the important role our intestinal habitants play in metabolism—they may also modulate the efficacy of certain cancer therapeutics. Iida et al. (p. 967) evaluated the impact of the microbiota on the efficacy of an immunotherapy [CpG (the cytosine, guanosine, phosphodiester link) oligonucleotides] and oxaliplatin, a platinum compound used as a chemotherapeutic. Both therapies were reduced in efficacy in tumor-bearing mice that lacked microbiota, with the microbiota important for activating the innate immune response against the tumors. Viaud et al. (p. 971) found a similar effect of the microbiota on tumor-bearing mice treated with cyclophosphamide, but in this case it appeared that the microbiota promoted an adaptive immune response against the tumors. The gut microbiota promote the efficacy of several antineoplastic agents in mice. The gut microbiota influences both local and systemic inflammation. Inflammation contributes to development, progression, and treatment of cancer, but it remains unclear whether commensal bacteria affect inflammation in the sterile tumor microenvironment. Here, we show that disruption of the microbiota impairs the response of subcutaneous tumors to CpG-oligonucleotide immunotherapy and platinum chemotherapy. In antibiotics-treated or germ-free mice, tumor-infiltrating myeloid-derived cells responded poorly to therapy, resulting in lower cytokine production and tumor necrosis after CpG-oligonucleotide treatment and deficient production of reactive oxygen species and cytotoxicity after chemotherapy. Thus, optimal responses to cancer therapy require an intact commensal microbiota that mediates its effects by modulating myeloid-derived cell functions in the tumor microenvironment. These findings underscore the importance of the microbiota in the outcome of disease treatment.
Subfields: Biological Psychiatry, Immunology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/81b04a13f5862b3253da7006df7d269ecffc295b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biological Psychiatry
In Immunology
In Molecular Biology
- Guido Kroemer
- L. Galluzzi
- Oliver Kepp
- L. Zitvogel
- Y. Belkaid
- Ian A. Wilson
- Jeremy K. Nicholson
- Zhijian J. Chen
Citations in the corpus
- The microbiome and human cancer (2021, background): “Tumor-associated, NOX2-mediated, myeloid cell ROS production is reduced by antibiotic administration or germ-free status, reducing oxaliplatin’s capacity to mediate early tumor genotoxicity (90).”
- Homeostatic immunity and the microbiota (2017, positive): “Disruption of the gut flora via antibiotic treatment or in germ free mice also impairs the capacity of the host to control subcutaneous tumors during immunotherapy (Iida et al., 2013).”
- Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy (2017, background): “Recent mouse studies have shown that the gut microbiota may modulate local immune responses and in turn affect chemotherapy (Iida et al., 2013; Viaud et al., 2013) and immunotherapy (Sivan et al., 2015; Vétizou et al., 2015).”
- The interaction of anticancer therapies with tumor-associated macrophages (2015, background): “In particular, microbial education of myelomonocytic cells is essential to prime for the antitumor activity of platinum combined with CpG (Fig. 3; Iida et al., 2013).”
- Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. (2016, background): “For instance, antibiotic treatment has been shown to impair responses to intratumoral CpG-oligodeoxynucleotide (ODN) injection or oxaliplatin administration in mice by reducing the induction of necrosis (via TNF-/), the magnitude of CD8 T cell responses, as well as the production of reactive oxygen ”
- The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health (2020, methodology): “Clinically relevant, the study indicated that when there is a reduction in Alistipes, there is a parallel reduction in optimal responses to cancer immunotherapy (61).”
- Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. (2016, background): “Hence, Iida et al. exemplified that TLR4 was important for the efficacy of platinum salts in modulating intratumoral MDSC and inducing antitumor effects and demonstrated that LPS could partially compensate for the reduced tumoricidal activity of oxaliplatine in ATB-treated mice (Iida et al., 2013).”
- Role of the Microbiota in Immunity and inflammation (2014, background): “In these experimental settings, the protective effect results from the capacity of the commensalderived ligands to control the status of activation of tumor myeloid cells and, more particularly, their level of TNF-a and reactive oxygen species, both associated with optimal tumor control (Iida et al.”